These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Chávez-Bueno S, Mejías A, Merryman RA, Ahmad N, Jafri HS, Ramilo O. Pediatr Infect Dis J; 2007 Dec 28; 26(12):1089-93. PubMed ID: 18043443 [Abstract] [Full Text] [Related]
10. Respiratory syncytial virus infection following hematopoietic stem cell transplantation. Small TN, Casson A, Malak SF, Boulad F, Kiehn TE, Stiles J, Ushay HM, Sepkowitz KA. Bone Marrow Transplant; 2002 Feb 28; 29(4):321-7. PubMed ID: 11896429 [Abstract] [Full Text] [Related]
11. Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. Khanna N, Widmer AF, Decker M, Steffen I, Halter J, Heim D, Weisser M, Gratwohl A, Fluckiger U, Hirsch HH. Clin Infect Dis; 2008 Feb 01; 46(3):402-12. PubMed ID: 18181739 [Abstract] [Full Text] [Related]
12. Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins. Ghosh S, Champlin RE, Ueno NT, Anderlini P, Rolston K, Raad I, Kontoyiannis D, Jacobson K, Luna M, Tarrand J, Whimbey E. Bone Marrow Transplant; 2001 Aug 01; 28(3):271-5. PubMed ID: 11535995 [Abstract] [Full Text] [Related]
13. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients. Liu V, Dhillon GS, Weill D. Transpl Infect Dis; 2010 Feb 01; 12(1):38-44. PubMed ID: 19761558 [Abstract] [Full Text] [Related]
14. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host. Wendt CH, Hertz MI. Semin Respir Infect; 1995 Dec 01; 10(4):224-31. PubMed ID: 8668850 [Abstract] [Full Text] [Related]
15. Respiratory syncytial virus infection in the late bone marrow transplant period: report of three cases and review. Khushalani NI, Bakri FG, Wentling D, Brown K, Mohr A, Anderson B, Keesler C, Ball D, Bernstein ZP, Bernstein SH, Czuczman MS, Segal BH, McCarthy PL. Bone Marrow Transplant; 2001 May 01; 27(10):1071-3. PubMed ID: 11438823 [Abstract] [Full Text] [Related]
16. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Pediatrics; 2003 Dec 01; 112(6 Pt 1):1442-6. PubMed ID: 14654627 [Abstract] [Full Text] [Related]
17. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. Groothuis JR, Simoes EA, Levin MJ, Hall CB, Long CE, Rodriguez WJ, Arrobio J, Meissner HC, Fulton DR, Welliver RC. N Engl J Med; 1993 Nov 18; 329(21):1524-30. PubMed ID: 8413475 [Abstract] [Full Text] [Related]
18. Pre-emptive use of aerosolized ribavirin in the treatment of asymptomatic pediatric marrow transplant patients testing positive for RSV. Adams R, Christenson J, Petersen F, Beatty P. Bone Marrow Transplant; 1999 Sep 18; 24(6):661-4. PubMed ID: 10490733 [Abstract] [Full Text] [Related]
19. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome. Avetisyan G, Mattsson J, Sparrelid E, Ljungman P. Transplantation; 2009 Nov 27; 88(10):1222-6. PubMed ID: 19935377 [Abstract] [Full Text] [Related]
20. Effectiveness of RSVIG prophylaxis and therapy of respiratory syncytial virus in an immunosuppressed animal model. Ottolini MG, Porter DD, Hemming VG, Zimmerman MN, Schwab NM, Prince GA. Bone Marrow Transplant; 1999 Jul 27; 24(1):41-5. PubMed ID: 10435733 [Abstract] [Full Text] [Related] Page: [Next] [New Search]